Seeing Is Believing
XENE is currently covered by 10 analysts with an average potential upside of $11.08 (52.92%) backed by displayed 27 price targets and 78 ratings.
Analysts average stock forecasts to be materialized ratio is 47.65% with an average time for these price targets to be met of 412.08 days.
Highest price target for XENE is 44, Lowest price target is 16, average price target is 30.
Most recent stock forecast was given by LAURA CHICO from WEDBUSH on 10-Aug-2023. First documented stock forecast 16-Dec-2014.
Currently, out of the existing stock ratings of XENE - 35 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
47
$11.16 (31.14%)
47
1 months 11 days ago
2/8 (25%)
$10.79 (40.28%)
435
Buy
50
$14.16 (39.51%)
50
1 months 11 days ago
2/8 (25%)
$13.01 (45.99%)
328
Buy
51
$15.16 (42.30%)
51
2 months 4 days ago
4/9 (44.44%)
$10.66 (42.61%)
579
Buy
49
$13.16 (36.72%)
49
3 months 6 days ago
1/4 (25%)
$12.67 (66.95%)
745
Buy
54
$18.16 (50.67%)
55
8 months 17 days ago
0/2 (0%)
$18.16 (50.26%)
What is XENE (Xenon Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on XENE (Xenon Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on XENE (Xenon Pharmaceuticals)?
Which analyst is the currently most bullish on XENE (Xenon Pharmaceuticals)?
Which analyst is the currently most reserved on XENE (Xenon Pharmaceuticals)?